CVM has approved the supplemental new animal drug application (NADA) for Terramycin® 200 for Fish. The supplemental approval of Terramycin® 200 for Fish (oxytetracycline) Type A medicated article provides for a change in the bacterial species of Aeromonas liquefaciens to Aeromonas hydrophila in the approved indications for salmonids and catfish.
August 30, 2018
CVM has approved the supplemental new animal drug application (NADA) for Terramycin® 200 for Fish.
The supplemental approval of Terramycin® 200 for Fish (oxytetracycline) Type A medicated article provides for a change in the bacterial species of Aeromonas liquefaciens to Aeromonas hydrophila in the approved indications for salmonids and catfish.
DIVERSIFY project achieves goal to help diversify aquaculture production in the EU
What you should know about producing both floating and sinking feeds
Volac unveils new feed additives division
Corteva, Bunge partner to develop amino acid-enhanced soybeans
Evonik expands production capacity for methionine in Singapore
Aquasoja offers single feed for seabass and seabream late pre-on growing stage
Multi X launches 100% carbon-neutral certified salmon
ASC opens consultation on fish health and welfare and a new pike-perch module
World Economic Forum’s Blue Food Partnership launches roadmap to strengthen sustainable growth in aquaculture
Selko 2022 Mycotoxin Review: Regional and seasonal challenges may be considered by feed manufacturers
Cargill's world mycotoxin report: Contamination is the rule
This website uses cookies to improve the user experience. Read our privacy policy to know more.